SML1662

Buparvaquone

≥98% (HPLC)

• Synonym(s): 1,4-Naphthalenedione,2-[[4-(1,1-dimethylethyl)cyclohexyl]methyl]-3-, Butalex, UNII-0354RT7LG4, 2-[(4-tert-Butylcyclohexyl)methyl]-3-hydroxy-1,4-naphthoquinone, 2-[[4-(1,1-Dimethylethyl)cyclohexyl]methyl]-3-hydroxy-1,4-naphthalenedione
• Empirical Formula (Hill Notation): C₂₁H₂₆O₃
• CAS Number: 88426-33-9
• Molecular Weight: 326.43
• MDL number: MFCD01712789
• UNSPSC Code: 12352200
• PubChem Substance ID: 329826000
• NACRES: NA.77

Properties

• Quality Level: 200
• assay: ≥98% (HPLC)
• form: powder
• solubility: DMSO: soluble; chloroform: soluble
• storage temp.: 2-8°C
• SMILES string: CC(C)(C)C1CCC(CC1)CC2=C(O)C(=O)c3ccccc3C2=O
• InChI: 1S/C21H26O3/c1-21(2,3)14-10-8-13(9-11-14)12-17-18(22)15-6-4-5-7-16(15)19(23)20(17)24/h4-7,13-14,24H,8-12H2,1-3H3
• InChI key: KLLIVCPQDTYMLC-UHFFFAOYSA-N

Description

Biochem/physiol Actions

Buparvaquone is a second-generation hydroxynaphthoquinone antiprotozoal drug related to parvaquone and atovaquone. Buparvaquone is indicated for the therapy and prophylaxis of all forms of Theileriosis and found to have an anti-Leishmanial activity.

Safety Information

• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable